GO:1905364 regulation of endosomal vesicle fusion: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905364 (regulation of endosomal vesicle fusion) is a biological process that modulates the frequency, rate or extent of endosomal vesicle fusion.
• Endosomal vesicle fusion is driven by SNARE proteins, Rab GTPases, tethering factors and Ca2+-sensing machinery, and is tightly regulated to control cargo delivery and signaling.
• Dysregulation of endosomal fusion contributes to cancer, neurodegeneration, metabolic disorders and immune dysfunction.
• Key proteins include RAB5, RAB7, EEA1, VPS34, SNAREs (VAMP7, STX7), and Ca2+ sensors such as synaptotagmins.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of regulatory nodes in endosomal fusion.
• EDITGENE provides end-to-end CRISPR services including library screening and bioinformatics to accelerate endosomal trafficking research.
Description
Endosomal vesicle fusion is a fundamental step in intracellular membrane trafficking, responsible for delivering cargo from early endosomes to late endosomes and lysosomes, as well as for recycling to the plasma membrane. The regulation of this process, annotated as GO:1905364, encompasses any mechanism that modulates the frequency, rate or extent of endosomal vesicle fusion. This regulation ensures proper sorting of receptors, nutrients and signaling molecules, and its disruption is linked to a wide range of diseases. Understanding how endosomal fusion is controlled at the molecular level is therefore critical for both basic cell biology and therapeutic development. Recent advances have identified conserved machineries, including Rab GTPases, SNAREs, tethering complexes and Ca2+-dependent regulators, that orchestrate the specificity and timing of fusion events. Moreover, cross-talk with autophagy and exosome biogenesis pathways highlights the broader physiological significance of this process. This article integrates authoritative GO annotations with real PubMed literature to provide a research-grade overview of GO:1905364, its key genes, disease relevance and experimental strategies for investigation.
regulation of endosomal vesicle fusion At A Glance
| GO ID | GO:1905364 |
|---|---|
| GO term | regulation of endosomal vesicle fusion |
| Ontology | biological_process |
| Synonym | regulation of endosome vesicle fusion |
| Major function | Modulates the frequency, rate or extent of endosomal vesicle fusion |
| Related processes | Endosomal trafficking, autophagy, exosome secretion |
| Key regulators | Rab GTPases, SNAREs, tethering factors, Ca2+ sensors |
| Disease relevance | Cancer, neurodegeneration, metabolic disorders, immune dysfunction |
What Is GO:1905364?
GO:1905364, regulation of endosomal vesicle fusion, is defined as any process that modulates the frequency, rate or extent of endosomal vesicle fusion. In other words, it includes all molecular events that control when, where and how efficiently endosomal membranes merge with target membranes, ensuring proper cargo delivery and organelle homeostasis.
Why Is regulation of endosomal vesicle fusion Important in Cell Biology?
Regulation of endosomal vesicle fusion is essential for cellular homeostasis because it controls the delivery of receptors, nutrients and signaling molecules to appropriate destinations. Defects in this process lead to impaired lysosomal degradation, altered growth factor signaling and accumulation of toxic protein aggregates, which are hallmarks of cancer and neurodegeneration. Furthermore, endosomal fusion is hijacked by pathogens and influences immune responses, making it a target for therapeutic intervention. Understanding its regulatory mechanisms provides insights into fundamental cell biology and offers potential biomarkers and drug targets.
• Controls cargo delivery from early to late endosomes and lysosomes.
• Regulates receptor recycling and downregulation, impacting cell signaling.
• Integrates with autophagy to maintain proteostasis.
• Influences exosome biogenesis and secretion.
• Dysregulation is linked to cancer progression and metastasis.
• Implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Affects metabolic disorders through GLUT4 trafficking.
• Modulates immune cell functions, including mast cell secretion.
• Provides targets for antiviral and anti-inflammatory therapies.
• Offers opportunities for CRISPR-based functional genomics.
What Happens During regulation of endosomal vesicle fusion?
Vesicle tethering and docking
In simple terms: Before membranes can fuse, the vesicle must be tied to the target membrane.
Tethering factors such as EEA1 and the CORVET/HOPS complexes are recruited by active Rab GTPases to bridge vesicles and target membranes, ensuring specificity. This step is regulated by Rab conversion and phosphoinositide lipids, which recruit and activate the tethering machinery.
SNARE complex assembly
In simple terms: SNARE proteins on the vesicle and target membranes twist together to pull the membranes close.
Assembly of trans-SNARE complexes, involving R-SNAREs (e.g., VAMP7) and Q-SNAREs (e.g., STX7, VTI1B), provides the energy for membrane fusion. Regulation occurs through SNARE disassembly by NSF/α-SNAP and through accessory proteins that proofread SNARE pairing.
Calcium-dependent regulation
In simple terms: Calcium acts as a switch to trigger fusion at the right time.
Ca2+ sensors such as synaptotagmins and calmodulin modulate endosomal fusion in response to intracellular Ca2+ signals. This regulation is critical for constitutive and regulated trafficking pathways, including GLUT4 exocytosis.
Rab GTPase cycling
In simple terms: Rab proteins act as molecular switches that turn fusion on and off.
Rab5 and Rab7 coordinate the transition from early to late endosomes, with their GTPase cycles regulated by GEFs, GAPs and GDIs. Dysregulation of Rab cycling alters fusion efficiency and cargo sorting.
Membrane lipid modulation
In simple terms: Lipids in the membrane help recruit and activate fusion proteins.
Phosphatidylinositol 3-phosphate (PI3P) and other phosphoinositides recruit effector proteins such as EEA1 and the retromer, thereby regulating fusion site assembly. Lipid-modifying enzymes like VPS34 are key regulators of this process.
Key Genes Involved in GO:1905364 regulation of endosomal vesicle fusion
The following genes encode core components and regulators of endosomal vesicle fusion, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAB5A | Early endosome fusion regulator | KO models show impaired endosome maturation |
| RAB7A | Late endosome/lysosome fusion | Mutations linked to neuropathy |
| EEA1 | Tethering factor for early endosomes | Knockdown disrupts endosomal fusion |
| VPS34 | PI3P synthesis for fusion site recruitment | Inhibitors affect autophagy and endocytosis |
| STX7 | Q-SNARE for late endosome fusion | KO impairs lysosomal delivery |
| VAMP7 | R-SNARE for late endosome fusion | Regulates lysosomal secretion |
| VTI1B | Q-SNARE involved in endosomal fusion | KO affects endosome maturation |
| NSF | SNARE disassembly | ATPase required for fusion cycles |
| α-SNAP | SNARE disassembly cofactor | Regulates SNARE recycling |
| SYT7 | Ca2+-dependent membrane fusion | Modulates lysosomal exocytosis |
| MFN1 | Mitochondrial fusion, interorganelle communication | Interactome links to autophagy |
| MFN2 | Mitochondrial fusion, ER tethering | Mutations cause Charcot-Marie-Tooth |
| GLUT4 | Insulin-responsive glucose transporter | Trafficking regulated by endosomal fusion |
| RAB27A | Secretory granule fusion | Mutations cause Griscelli syndrome |
| STXBP1 | SNARE regulator | Mutations linked to encephalopathy |
| VPS35 | Retromer component | Mutations linked to Parkinson's |
| LAMP1 | Lysosomal marker | Used to assess fusion efficiency |
How Is regulation of endosomal vesicle fusion Regulated?
Regulation of endosomal vesicle fusion is controlled at multiple levels, including Rab GTPase cycling, Ca2+ signaling, and phosphorylation by kinases such as mTOR and AMPK. Autophagy-related machinery also intersects with endosomal fusion, as autophagosome maturation requires fusion with endosomes and lysosomes. Additionally, interorganelle communication via MFN1/MFN2 influences autophagic flux and endosomal dynamics.
regulation of endosomal vesicle fusion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RAB7A | Charcot-Marie-Tooth neuropathy | Knockout or point-mutation in neuronal cells |
| VPS35 | Parkinson's disease | Knock-in of disease variants in iPSCs |
| GLUT4 | Type 2 diabetes | Overexpression or KO in adipocytes |
| RAB27A | Griscelli syndrome | KO in mast cells or melanocytes |
| MFN2 | Charcot-Marie-Tooth type 2A | Knockout in motor neurons |
Cancer
Altered endosomal fusion promotes tumor progression by enhancing recycling of growth factor receptors and integrins, leading to sustained proliferative signaling and metastasis. Dysregulation of Rab GTPases and SNAREs has been observed in various cancers.
Neurodegeneration
Impaired endosomal-lysosomal fusion contributes to the accumulation of toxic protein aggregates in Alzheimer's and Parkinson's diseases. Mutations in RAB7A and VPS35 are linked to hereditary neuropathies and Parkinson's disease, respectively.
Metabolic disorders
Defective endosomal fusion affects GLUT4 trafficking, contributing to insulin resistance and type 2 diabetes. Proper regulation is essential for glucose homeostasis.
Immune dysfunction
Endosomal fusion is critical for antigen presentation and mast cell secretion; defects can lead to immune deficiencies and allergic disorders. Exosome secretion also depends on endosomal fusion, impacting intercellular communication.
From regulation of endosomal vesicle fusion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endosomal fusion? | CRISPR knockout in HeLa or HEK293 cells |
| What is the effect of a disease-associated point mutation? | Point-mutation knock-in via CRISPR |
| How does a fusion protein localize dynamically? | Tagged knock-in with fluorescent protein |
| Can overexpression rescue a fusion defect? | Overexpression of wild-type or mutant gene |
| Which genes are essential for endosomal fusion? | Genome-wide CRISPR library screening |
| How does Ca2+ regulate fusion? | Live-cell imaging with Ca2+ indicators |
How to Study the regulation of endosomal vesicle fusion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Fusion frequency and dynamics | Real-time visualization of endosomal fusion |
| Proteomics | Protein interactions and complexes | Identifying novel regulators |
| CRISPR screening | Gene essentiality for fusion | Discovery of regulatory genes |
| In vitro fusion assay | Fusion rate and factor requirements | Mechanistic dissection |
| RNA-seq | Transcriptional changes | Pathway analysis after KO |
| Western blot | Protein expression and processing | Validation of KO/overexpression |
| Immunofluorescence | Localization of fusion markers | Assessing fusion defects |
| Ca2+ imaging | Intracellular calcium levels | Linking Ca2+ to fusion |
Live-cell imaging
Fluorescently tagged endosomal markers (e.g., GFP-RAB5, LAMP1-mCherry) allow real-time visualization of fusion events and quantification of fusion frequency. This method is essential for assessing regulatory effects of candidate genes.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry identifies protein complexes involved in endosomal fusion, such as SNARE complexes and Rab effectors. This approach reveals dynamic changes in interactomes under different conditions.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate endosomal fusion, using reporters of cargo delivery or lysosomal function. Hits are validated by targeted KO and imaging.
Biochemical fusion assays
In vitro fusion assays using purified endosomes and cytosol measure the rate of membrane fusion and the requirement for specific factors like NSF, α-SNAP and Rab GTPases. These assays provide mechanistic insights into regulatory components.
How CRISPR Can Be Used to Study GO:1905364 regulation of endosomal vesicle fusion
Knockout
CRISPR knockout of candidate regulators (e.g., RAB5A, EEA1) enables loss-of-function studies to determine their necessity in endosomal fusion. KO cells can be analyzed by imaging and biochemical assays.
Point Mutation
Introducing disease-associated point mutations (e.g., in RAB7A or VPS35) via CRISPR allows precise modeling of functional consequences on fusion. This approach distinguishes gain- vs loss-of-function effects.
Knock-in
Tagged knock-in of endosomal proteins (e.g., GFP-LAMP1) facilitates live-cell tracking of fusion events without overexpression artifacts. Knock-in of reporter cassettes can also monitor fusion flux.
Overexpression
Overexpression of wild-type or mutant cDNAs (e.g., GLUT4, RAB27A) can rescue or exacerbate fusion defects, providing insights into regulatory mechanisms. This is useful for structure-function studies.
How EDITGENE Supports regulation of endosomal vesicle fusion Research
Researchers studying regulation of endosomal vesicle fusion-related genes often need to determine whether a candidate gene is causally involved in fusion regulation or merely correlated with it. This requires precise genetic manipulation, which is best achieved through CRISPR-based models. EDITGENE offers a comprehensive suite of services to generate and analyze such models, accelerating discovery in endosomal biology.
Contact EDITGENE today to design your custom CRISPR model for regulation of endosomal vesicle fusion research.
Frequently Asked Questions About regulation of endosomal vesicle fusion
What is GO:1905364?
GO:1905364 is the Gene Ontology term for regulation of endosomal vesicle fusion, defined as any process that modulates the frequency, rate or extent of endosomal vesicle fusion.
What genes are involved in regulation of endosomal vesicle fusion?
Key genes include RAB5A, RAB7A, EEA1, VPS34, STX7, VAMP7, VTI1B, NSF, α-SNAP, and SYT7, among others.
How is endosomal vesicle fusion regulated?
It is regulated by Rab GTPase cycling, SNARE complex assembly, Ca2+ signaling, and lipid modifications, ensuring timely and specific membrane fusion.
What diseases are linked to defective endosomal vesicle fusion?
Defects are linked to cancer, neurodegeneration (e.g., Parkinson's, Alzheimer's), metabolic disorders like diabetes, and immune dysfunction.
What methods are used to study regulation of endosomal vesicle fusion?
Common methods include live-cell imaging, proteomics, CRISPR screening, in vitro fusion assays, and biochemical analyses.
Can CRISPR be used to study endosomal vesicle fusion?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in endosomal fusion.
What is the role of Rab GTPases in endosomal fusion?
Rab GTPases act as molecular switches that recruit tethering factors and SNAREs to coordinate membrane fusion.
How does calcium regulate endosomal vesicle fusion?
Calcium sensors such as synaptotagmins trigger fusion in response to Ca2+ signals, modulating both constitutive and regulated trafficking.
What is the connection between endosomal fusion and autophagy?
Autophagosome maturation requires fusion with endosomes and lysosomes, and regulatory components are shared between these pathways.
How can I model endosomal fusion defects in the lab?
CRISPR-engineered cell lines with knockouts, point mutations, or tagged knock-ins of key regulators are ideal for modeling fusion defects.
Conclusion
Regulation of endosomal vesicle fusion (GO:1905364) is a central process in membrane trafficking that ensures proper cargo delivery and cellular homeostasis. Its dysregulation underlies numerous human diseases, making it a vibrant area of research. By leveraging CRISPR-based models and advanced screening technologies, researchers can uncover new regulatory mechanisms and therapeutic targets. EDITGENE stands ready to support these efforts with tailored gene editing and bioinformatics services.
References
- 1. Arya SB et al.. 2024. The ins-and-outs of exosome biogenesis, secretion, and internalization.. Trends Cell Biol 34(2):90-108 PMID: 37507251
- 2. Zhao YG et al.. 2021. Machinery, regulation and pathophysiological implications of autophagosome maturation.. Nat Rev Mol Cell Biol 22(11):733-750 PMID: 34302147
- 3. Sargeant J et al.. 2022. Ca(2+) regulation of constitutive vesicle trafficking.. Fac Rev 11:6 PMID: 35359486
- 4. Gautreau A et al.. 2014. Function and regulation of the endosomal fusion and fission machineries.. Cold Spring Harb Perspect Biol 6(3) PMID: 24591520
- 5. Stöckli J et al.. 2011. GLUT4 exocytosis.. J Cell Sci 124(Pt 24):4147-59 PMID: 22247191
- 6. Gordaliza-Alaguero I et al.. 2025. Endogenous interactomes of MFN1 and MFN2 provide novel insights into interorganelle communication and autophagy.. Autophagy 21(5):957-978 PMID: 39675054
- 7. van der Goot FG et al.. 2006. Intra-endosomal membrane traffic.. Trends Cell Biol 16(10):514-21 PMID: 16949287
- 8. Omari S et al.. 2024. Mast cell secretory granule fusion with amphisomes coordinates their homotypic fusion and release of exosomes.. Cell Rep 43(7):114482 PMID: 38985670
